ForMyGluco
BlogGlossary← Home

Day-to-day use

What happens to medications on sick days?

· 2 min

Close-up of a dusty pink quilt with a raised texture; one corner has curled into a roll, and a soft shadow sits in the diagonal fold.

A day with fever, vomiting, or diarrhea pulls blood sugar in two directions at once. Illness stress pushes it up; not eating and fluid loss pull it down. Some drugs also act differently on such days, because the body’s fluid balance and kidney speed don’t hold. When balance shifts, the drug’s job shifts too.

A feverish infection puts the body on alert, pushing up counter-regulatory hormones like cortisol, adrenaline, and glucagon. They blunt how tissues answer insulin and speed the liver’s sugar production. So being sick carries blood sugar up even without eating. Another force works against this. Vomiting and diarrhea take both food and fluid, pulling the picture the other way.

The real fragile point: running out of fluid. As fluid drops, kidney blood flow falls and the kidney clears substances from the blood more slowly. Drugs leaving mainly through the kidney feel that slowdown directly. Metformin is the best-known example: what normally exits fine builds up in the blood when that exit narrows, straining the lactic acid balance.

SGLT-2 inhibitors follow a separate route. Because this family sends sugar out in the urine, it already raises fluid loss; the illness’s loss stacks on top. There’s a second effect too. It shifts the insulin and glucagon balance, the body turns to fat for fuel, and ketone production speeds up. The resulting acid picture can develop even when the reading doesn’t look high; the literature calls it “euglycemic ketoacidosis”.

Both pictures are rare. Rare doesn’t mean unimportant when conditions stack up. The reason for that fragility varies from family to family; each family’s weak point sits elsewhere.

  • Metformin: its exit runs almost wholly through the kidney, which fluid loss narrows first.
  • SGLT-2 inhibitor: deepens fluid loss and makes ketone production easier.
  • Sulfonylurea: keeps prompting the pancreas; without food, low sugar grows likelier.
  • GLP-1 receptor agonist: slows stomach emptying, deepens nausea and loss of appetite.
  • Some blood pressure drugs and water pills: push fluid loss and kidney load in the same direction.
  • Insulin: reversed on this list; the need doesn’t vanish.

Insulin really does sit elsewhere on this list. During an infection the body’s insulin need doesn’t shrink; most often it grows. Insulin dropping out altogether because the plate stayed empty opens a second door on top of the first problem: the body shifts to burning fat and ketones pile up. So being unable to eat doesn’t zero the insulin need by itself.

Here’s the sum of all this. What happens on a sick day depends on the drug family, kidney status, whether food stays down, and how many days the illness runs. A single general sentence can’t cover these four variables at once. So sick day rules are a ready-made plan the person builds with the care team while healthy. New decisions come hard when fever climbs and sleep is broken. A text written beforehand moves the decision to a healthy day. Some keep that paper in the nightstand drawer, by the thermometer.

Sources

  1. Watson KE, Dhaliwal K, Robertshaw S, Verdin N, Benterud E, Lamont N, Drall KM, McBrien K, Donald M, Tsuyuki RT, Campbell DJT, Pannu N, James MT. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process. American Journal of Kidney Diseases. 2023;81(5):564-574.
  2. Dyatlova N, Tobarran NV, Kannan L, North R, Wills BK. Metformin-Associated Lactic Acidosis (MALA). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. Last updated 2023 Apr 17.
  3. Somagutta MR, Agadi K, Hange N, Jain MS, Batti E, Emuze BO, Amos-Arowoshegbe EO, Popescu S, Hanan S, Kumar VR, Pormento MKL. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Cureus. 2021;13(3):e13665.
  4. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S183–S215. doi:10.2337/dc26-S009
  5. Brealey D, Singer M. Hyperglycemia in Critical Illness: A Review. Journal of Diabetes Science and Technology. 2009;3(6):1250-1260.

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog